Proglumetacin maleate

This classification denotes an indoleacetic acid and non-steroidal anti-inflammatory agent with the molecular formula C46H58ClN5O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FV919079LU, chemically known as 3-(4-(2-hydroxyethyl)-1-piperazinyl)propyl dl-4-benzamido-n,n-dipropylglutaramate 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetate (ester) but more generally known as proglumetacin, which bears US NIH Compound Identifier 4921. European Medicines Agency schedules Proglumetacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10077MIG. World Health Organization schedules proglumetacin in its Anatomical Therapeutic Chemical (ATC) Classification. PROGLUMETACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule proglumetacin maleate under HS 29335995 and SITC 51576. As of Q4 2014, PROGLUMETACIN MALEATE remains US FDA's Preferred Term for this commodity. SMILES: CCCN(C(=O)C(NC(=O)C1CCCCC1)CCC(=O)OCCCN2CCN(CC2)CCOC(=O)CC3C4C(N(C3C)C(=O)C5CCC(CC5)CL)CCC(C4)OC)CCC.C(=C\C(=O)O)\C(=O)O.C(=C\C(=O)O)\C(=O)O.